Player FM 앱으로 오프라인으로 전환하세요!
Episode 913: Vasopressors after ROSC
Manage episode 430292863 series 2942787
Contributor: Travis Barlock MD
Educational Pearls:
Recent study assessed outcomes after ROSC with epinephrine vs. norepinephrine
Observational multicenter study from 2011-2018
285 patients received epineprhine and 481 received norepinephrine
Epinephrine was associated with an increase in all-cause mortality (primary outcome)
Odds ratio 2.6; 95%CI 1.4-4.7; P = 0.002
Higher cardiovascular mortality (secondary outcome)
Higher proportion of unfavorable neurological outcome (secondary outcome)
Norepinephrine is the vasopressor of choice in post-cardiac arrest care
References
Bougouin W, Slimani K, Renaudier M, et al. Epinephrine versus norepinephrine in cardiac arrest patients with post-resuscitation shock. Intensive Care Med. 2022;48(3):300-310. doi:10.1007/s00134-021-06608-7
Summarized by Jorge Chalit, OMSIII | Edited by Meg Joyce & Jorge Chalit
1068 에피소드
Manage episode 430292863 series 2942787
Contributor: Travis Barlock MD
Educational Pearls:
Recent study assessed outcomes after ROSC with epinephrine vs. norepinephrine
Observational multicenter study from 2011-2018
285 patients received epineprhine and 481 received norepinephrine
Epinephrine was associated with an increase in all-cause mortality (primary outcome)
Odds ratio 2.6; 95%CI 1.4-4.7; P = 0.002
Higher cardiovascular mortality (secondary outcome)
Higher proportion of unfavorable neurological outcome (secondary outcome)
Norepinephrine is the vasopressor of choice in post-cardiac arrest care
References
Bougouin W, Slimani K, Renaudier M, et al. Epinephrine versus norepinephrine in cardiac arrest patients with post-resuscitation shock. Intensive Care Med. 2022;48(3):300-310. doi:10.1007/s00134-021-06608-7
Summarized by Jorge Chalit, OMSIII | Edited by Meg Joyce & Jorge Chalit
1068 에피소드
Tous les épisodes
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.